P-Rex1 is activated by human epidermal growth factor receptor (HER2) and GPCRs, such as the chemokine receptor CXCR4 in breast cancer, and overexpressed in ER and HER2 positive luminal A and B breast cancer tissues compared to normal breast tissue. Here, PREX1 is linked to breast carcinoma.